Epigenetics discovery aids prostate cancer diagnosis

A lot of attention has been placed on the genetics of cancer, including looking at the mutations that occur that enable a small cohort of cells to maintain runaway growth. But cancer also sees changes occur at the epigenetic level, switching key genes on and off to enable it to grow and spread.

Now researchers at Sydney’s Garvan Institute have revealed the role of one non-coding microRNA (miRNA) which appears to play a significant role in prostate cancer and is closely linked to the prognosis of cancer patients. The discovery opens up the possibility of developing a new diagnostic tool as well as yielding an insight into how prostate cancer proliferates, and how it might potentially be stopped.

View the original article here: Epigenetics discovery aids prostate cancer diagnosis – Australian Life Scientist

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...

Most Popular

News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend